Biotechnology · Berkeley, CA · Founded 2023 · Privately Held (backing)
Operator of a biotechnology platform intended to enable precise genome editing inside the body for disease treatment. Azalea Therapeutics is based in Berkeley, CA and was founded in 2023. It was valued at $153 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $82 million across 1 recorded round; the latest was a $65 million Series A in Oct 2025.
These 6 firms already write checks for companies like Azalea Therapeutics in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.